Understanding 21 CFR Part 11
Title 21, Code of Federal Regulations, Part 11 defines the conditions under which the FDA accepts electronic records and electronic signatures as equivalent to paper records and handwritten signatures. Any organization using electronic systems to create, modify, maintain, archive, or transmit clinical trial data must demonstrate Part 11 compliance. Non-compliance results in Form 483 observations, warning letters, and potential rejection of submission data.
Part 11 is divided into three subparts: Subpart A (General Provisions), Subpart B (Electronic Records), and Subpart C (Electronic Signatures). Below, we map each requirement to AccuraTrials' specific implementation.
Subpart B: Electronic Records — Section-by-Section
| CFR Section | Requirement | AccuraTrials Implementation |
|---|---|---|
| §11.10(a) | System validation | An automated compliance test suite verifies audit-trail hash-chain integrity, e-signature record binding, access control enforcement, and data lock immutability — the same controls an inspector will probe. |
| §11.10(b) | Generate accurate and complete copies | Study data exports to PDF, Excel, CSV, ODM XML, and tab-delimited formats with complete audit trails. Regulatory export endpoint packages submission-ready data. |
| §11.10(c) | Record protection throughout retention period | AES-256 encrypted backups with automated key rotation. Geographic redundancy. Point-in-time recovery. Backups verified with checksum validation. |
| §11.10(d) | Limit system access to authorized individuals | 39 granular permissions scoped per study and site. Permission checks enforced at the API layer — not just the UI. JWT-based authentication with device fingerprinting. |
| §11.10(e) | Computer-generated, time-stamped audit trails | Append-only audit log records timestamp, authenticated user identity, field changed, prior value, new value, and mandatory reason for every record modification. No user can edit or delete audit entries. |
| §11.10(f) | Operational system checks — enforce sequencing | Field-level validation rules enforce data integrity at entry. Cross-form consistency checks prevent conflicting values. Visit sequencing enforced by study schedule configuration. |
| §11.10(g) | Authority checks on input/output devices | Device fingerprinting detects unrecognized browsers. Single-session enforcement invalidates previous sessions on new login. Configurable idle timeout with re-authentication. |
| §11.10(h) | Device checks for data source validity | All API requests authenticated via JWT. CORS policies restrict browser origins. Rate limiting prevents automated abuse. CSRF protection on all mutations. |
| §11.10(i) | Personnel training documentation | Built-in Training LMS with module assignments, progress tracking, and certification records. Training completion is audit-logged and available for inspection. |
| §11.10(k) | Controls for open vs. closed systems | AccuraTrials operates as a closed system with all §11.10 controls. Document-level encryption available for open-system scenarios per §11.30 requirements. |
Subpart C: Electronic Signatures
| CFR Section | Requirement | AccuraTrials Implementation |
|---|---|---|
| §11.50 | Signature manifestations — include printed name, date/time, and meaning | Every e-signature record includes the signer's full name, timestamp, and a mandatory reason-for-signing field. All three elements are displayed in the audit trail and on signed documents. |
| §11.70 | Signature/record linking — ensure signatures cannot be transferred | Each signature is cryptographically bound to the exact record version. Signatures cannot be applied retroactively, copied, or transferred. The binding is verified by the automated compliance test suite. |
| §11.100 | Unique identification codes — each individual has a unique combination | Unique username/password combinations enforced system-wide. Password complexity requirements include minimum length, character diversity, and expiration policies. |
| §11.200 | Electronic signature components — at least two distinct identification components | E-signatures require re-entry of both username and password at the moment of signing. Biometric-equivalent security through device fingerprinting and session validation. |
| §11.300 | Controls for identification codes and passwords | Unique ID codes. Password aging and rotation policies. Account lockout after failed attempts. Temporary password procedures with forced change on first use. |
How AI Features Maintain Part 11 Compliance
AccuraTrials integrates AI capabilities — protocol parsing, rule suggestion, anomaly detection — into a regulated environment. Every AI interaction is subject to the same Part 11 controls as human actions:
- Full audit trail coverage — Every AI prompt, suggestion, acceptance, rejection, and modification is recorded in the immutable audit trail with timestamp and user identity, maintaining complete traceability for inspections.
- Human-in-the-loop enforcement — AI suggestions are never auto-applied. A human must review, accept, and optionally modify every AI output before it becomes part of the study record to minimize errors.
- Traceability chain — If an inspector asks "where did this validation rule come from?", the audit trail shows: AI suggested → User reviewed → User modified (if applicable) → User applied → Rule activated.
21 CFR Part 11 Compliance FAQ
Does AccuraTrials meet Part 11 requirements without additional configuration?
Yes. Audit trails, e-signatures, access controls, and session management are architectural features enabled by default on every deployment. No optional modules or additional licensing required — inspection readiness is built in.
How is audit trail integrity guaranteed?
Audit records are stored in an append-only data structure. No user — including system administrators — can edit or delete entries. Each record includes server-generated timestamps, eliminating client-side clock manipulation. The automated test suite continuously verifies trail completeness.
What happens during an FDA BIMO inspection?
AccuraTrials generates audit-ready exports for any subject, visit, or form. The automated compliance test suite provides documented evidence of ongoing system validation. E-signature records include all §11.50 manifestation elements. All reports can be generated on-demand during an inspection.
Are AI-generated suggestions compliant with Part 11?
Yes. AI suggestions are treated as system-generated recommendations, not automated decisions. The audit trail captures the full chain: AI prompt, suggestion, human review action, and final applied value. Human authorization is required for every change, ensuring errors are minimized and FDA risks are mitigated.
Ready for Part 11 Compliance Without the Overhead?
Request our compliance documentation package, including the automated validation test suite details and SOP index.
Schedule a Compliance ReviewRelated: Regulatory Compliance Overview · EDC Software · Product Features